| ACEIs | Angiotensin Converting Enzymes |
| AE | Adverse Events |
| AH | Arterial hypertension |
| AKI | Acute kidney injury |
| ARBs | Angiotensin receptor blockers |
| CI | Confidence intervals |
| CKD | Chronic kidney disease |
| COVID-19 | Coronavirus disease 2019 |
| COPD | Chronic obstructive pulmonary disease |
| CPAP | Continuous positive airway pressure |
| DM | Diabetes mellitus |
| eGFR | Estimated glomerular filtration rate |
| ESRD | End-stage renal disease |
| FANS | Non-steroidal anti-inflammatory drugs |
| HD | Haemodialysis |
| HFNC | High flow nasal cannula |
| ICU | Intensive care unit |
| KDIGO | Kidney Disease: Improving Global Outcomes |
| NA | Not available |
| PRES | Posterior reversible encephalopathy syndrome |
| RRT | Renal replacement therapy |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| UTI | Urinary tract infection |
| VM | Venturi mask |
| WHO | World Health Organization |